NASDAQ:BCORBlucora Stock Price, Forecast & News

Blucora's stock was trading at $13.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BCOR stock has decreased by 10.3% and is now trading at $11.70.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Blucora in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Blucora.

Blucora is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Blucora.

Blucora Inc (NASDAQ:BCOR) posted its quarterly earnings results on Wednesday, August, 5th. The information services provider reported $0.09 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.54 by $0.45. The information services provider had revenue of $161.10 million for the quarter, compared to analyst estimates of $186.55 million. Blucora had a negative net margin of 43.01% and a positive return on equity of 4.84%. The company's revenue for the quarter was down 16.8% compared to the same quarter last year. During the same period last year, the company earned $0.83 EPS.
View Blucora's earnings history.

Blucora issued an update on its FY20 earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of $0.83 to $0.98 for the period, compared to the Thomson Reuters consensus estimate of $1.11. The company issued revenue guidance of $733 million to $747 million, compared to the consensus revenue estimate of $743.36 million.

4 equities research analysts have issued 1 year price targets for Blucora's shares. Their forecasts range from $15.00 to $30.00. On average, they anticipate Blucora's share price to reach $22.75 in the next twelve months. This suggests a possible upside of 94.4% from the stock's current price.
View analysts' price targets for Blucora.

Press coverage about BCOR stock has trended negative this week, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Blucora earned a news sentiment score of -2.4 on InfoTrie's scale. They also assigned headlines about the information services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Blucora.

Blucora saw a decrease in short interest in June. As of June 30th, there was short interest totaling 995,700 shares, a decrease of 21.0% from the June 15th total of 1,260,000 shares. Based on an average daily trading volume, of 466,600 shares, the short-interest ratio is presently 2.1 days. Approximately 2.2% of the shares of the stock are sold short.
View Blucora's Short Interest.

Some companies that are related to Blucora include Facebook (FB), Equinix (EQIX), SEA (SE), eBay (EBAY), CoStar Group (CSGP), Twitter (TWTR), Verisign (VRSN), Akamai Technologies (AKAM), ANGI Homeservices (ANGI), Envestnet (ENV), Stamps.com (STMP), LogMeIn (LOGM), LivePerson (LPSN), J2 Global (JCOM) and Cimpress (CMPR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Blucora investors own include BlackRock (BLK), CA (CA), Chipotle Mexican Grill (CMG), Endologix (ELGX), Tesla (TSLA), Honda Motor (HMC), Wells Fargo & Co (WFC), Accenture (ACN), Aegean Marine Petroleum Network (ANW) and Alibaba Group (BABA).

Blucora trades on the NASDAQ under the ticker symbol "BCOR."

Blucora's stock is owned by many different institutional and retail investors. Top institutional shareholders include Federated Hermes Inc. (2.32%), FMR LLC (1.15%), Bank of New York Mellon Corp (1.12%), Empirical Financial Services LLC d.b.a. Empirical Wealth Management (1.02%), Principal Financial Group Inc. (0.75%) and Scout Investments Inc. (0.40%). Company insiders that own Blucora stock include Ann J Bruder, Christopher William Walters, H Mcintyre Gardner, John David Palmer, John S Clendening, Lance G Dunn, Mark A Ernst, Mary Slagle Zappone, Mathieu Frederic Stevenson, Michael P Hogan, Robert D Oros, Todd C Mackay and William L Atwell.
View institutional ownership trends for Blucora.

BCOR stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, State of Wisconsin Investment Board, Hancock Whitney Corp, Goldman Sachs Group Inc., State of Tennessee Treasury Department, Prudential Financial Inc., Principal Financial Group Inc., and UBS Group AG.
View insider buying and selling activity for Blucora.

BCOR stock was bought by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Empirical Financial Services LLC d.b.a. Empirical Wealth Management, Globeflex Capital L P, First Trust Advisors LP, SG Americas Securities LLC, Swiss National Bank, FMR LLC, and Bank of Montreal Can. Company insiders that have bought Blucora stock in the last two years include Christopher William Walters, Mark A Ernst, and Michael P Hogan.
View insider buying and selling activity for Blucora.

Shares of BCOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCOR stock can currently be purchased for approximately $11.70.

Blucora has a market capitalization of $562.04 million and generates $717.95 million in revenue each year. The information services provider earns $48.15 million in net income (profit) each year or $1.85 on an earnings per share basis. Blucora employs 529 workers across the globe.

The official website for Blucora is www.blucora.com.

Blucora's mailing address is 3200 Olympus Blvd Suite 100, Dallas TX, 75019. The information services provider can be reached via phone at 972-870-6400 or via email at [email protected]